| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/03/2006 | US20060173008 New pyridazin-3(2h)-one derivatives |
| 08/03/2006 | US20060173007 Compounds, compositions, and methods |
| 08/03/2006 | US20060173006 biphenyl and pyridylphenyl derivatives such as 2,6-Difluoro-N-[2'-methyl-5'-(pyridine-3-yl)-biphenyl-4-yl]-benzamide, used as immunosuppressants for the treatmet or prevent allergies, inflammatory and immune disorders |
| 08/03/2006 | US20060173005 Process for preparing nitrooxyderivative of naproxen |
| 08/03/2006 | US20060173004 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060173002 Heteroaryl compounds as P2Y1 receptor inhibitors |
| 08/03/2006 | US20060173001 Administering a 2-hydroxy-1,4-benzoxazin-3-one, a 4-hydroxy- or methoxy derivative, or a glucoside of the compound that has been obtained from a leafy and/or immature monocotyledonous plant, animal tissue or by chemical synthesis; fibromyalgia, disorder, hyperglycemia, arthritis, stress, or drug abuse |
| 08/03/2006 | US20060173000 5-(2-Morpholin-4-yl-ethyl)-1-(4-nitro-phenyl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carbonitrile; 5-isobutyl-1-(4-nitro-phenyl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carbonitrile; anti-retroviral agent |
| 08/03/2006 | US20060172999 2-[(1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-phenyl-tetrahydropyran-4-yl]methyl-2-oxa-8-aza-spiro[4,5]decan-4-ol; neurokinin 1 (NK-1) receptor antagonists; antidepressant, anxiolytic, analgesic, antiinflammatory agent; migraine, emesis or postherpetic neuralgia |
| 08/03/2006 | US20060172998 Method of preventing relapse in the abstinent substance dependent individual |
| 08/03/2006 | US20060172997 Combinations of inhibitors of reverse transcriptase and inhibitors of virus-encoded DNA polymerase |
| 08/03/2006 | US20060172996 Method of preventing relapse in the abstinent substance dependent individual |
| 08/03/2006 | US20060172995 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 08/03/2006 | US20060172994 Compounds useful as chemokine receptor antagonists |
| 08/03/2006 | US20060172993 Use of galantamine for the treatment of neuropsychiatric behaviour associated with Alzheimer's disease |
| 08/03/2006 | US20060172992 Therapeutic agent for overactive bladder resulting from cerebral infarction |
| 08/03/2006 | US20060172991 Use of inhibitors of Jun N-terminal kinases to treat glaucoma |
| 08/03/2006 | US20060172990 Antibacterial agents |
| 08/03/2006 | US20060172989 Aminoalkoxyphenyl indolone derivatives |
| 08/03/2006 | US20060172988 Azetidine compounds |
| 08/03/2006 | US20060172987 Amoxicillin trihydrate |
| 08/03/2006 | US20060172986 Polycarboxylated porphyrins and use thereof in treatment of metal toxicities |
| 08/03/2006 | US20060172985 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension |
| 08/03/2006 | US20060172984 Methods and compositions of novel triazine compounds |
| 08/03/2006 | US20060172983 biologically active compounds with aromatic hydroxyl, amino or carboxylic acid substituents are functionalized to form hydrolysable, bioabsorbable compounds which can be readily polymerized to form absorbable or biodegradable polymers |
| 08/03/2006 | US20060172982 Formulation comprising tetracycline or derivative and method of treating or preventing infections and inflammatory conditions |
| 08/03/2006 | US20060172980 Lyophile formulation of combretastatin A4 phosphate mono-tromethamine or histidine salt, wherein the pH is basified with sodium hydroxide or TRIS to prevent a pH drop during freezing; improved water solubility; rapidly regenerates combretastatin A-4 in vivo |
| 08/03/2006 | US20060172979 New use of GABAB receptor agonists |
| 08/03/2006 | US20060172978 Method of neutralising organoboronates with acids |
| 08/03/2006 | US20060172977 Topical administering an acetylcholine esterases inhibitor |
| 08/03/2006 | US20060172976 Ibandronate polymorph |
| 08/03/2006 | US20060172975 Ibandronate polymorph |
| 08/03/2006 | US20060172974 Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
| 08/03/2006 | US20060172973 Nucleobase substituted with a 2-hydroxy-4-oxobut-2-enoic acid or ester or a 1-hydroxy-3-oxopropenephosphonic acid or ester, e.g., Methyl 4-(1,3-dibenzyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-2-hydroxy-4-oxobut-2-enoate |
| 08/03/2006 | US20060172972 Formulation and method for administration of ophthalmologically active agents |
| 08/03/2006 | US20060172971 e.g. 2-[(2-bromo-4-fluoro-phenyl)-hydrazono]-propionic acid ethyl ester; protein tyrosine kinase inhibitor, but does not inhibit ATP binding to the protein tyrosine kinase; and as anticarcinogenic agent, psoriasis, atherosclerosis, or immune system activity |
| 08/03/2006 | US20060172970 Scleroderma; side effect reduction |
| 08/03/2006 | US20060172969 Citric acid, polyethylene glycol, and ofloxacin; low gelation temperatures; bioavailability |
| 08/03/2006 | US20060172968 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 08/03/2006 | US20060172967 Method for producing alkyl-esterified glycosaminoglycan |
| 08/03/2006 | US20060172966 Immunostimulatory G, U-containing oligoribonucleotides |
| 08/03/2006 | US20060172960 cellular senescence and immortalization; administering a telemerase inhibitor; reduced loss of telomere length; antiproliferative agents |
| 08/03/2006 | US20060172959 Selected rna motifs to include cell death and/or apoptosis |
| 08/03/2006 | US20060172956 Compositions and methods for the treatment of arthritis |
| 08/03/2006 | US20060172955 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060172954 Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product |
| 08/03/2006 | US20060172953 Treatment of benign prostatic hyperplasia using energolytic agents |
| 08/03/2006 | US20060172952 Aza-peptide epoxides |
| 08/03/2006 | US20060172951 Age related macular degeneration and cutaneous signs of mercury toxicity |
| 08/03/2006 | US20060172950 Hepatitis C virus inhibitors |
| 08/03/2006 | US20060172947 Physiologically active peptides and drugs containing the same |
| 08/03/2006 | US20060172945 Human neutrophil alpha-defensin 4 inhibition of HIV-1 |
| 08/03/2006 | US20060172939 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/03/2006 | US20060172928 providing a biomolecule such as nucleic acid, protein, antibody immobilized on a substrate (quartz, glass etc) covering with a nonreducing disaccharide trehalose or sucrose; a protein or peptide of Late Embryogenesis Abundant (LEA) class comprising a motif of 11 amino acids; biochip; storage stability |
| 08/03/2006 | US20060172922 Methods for combating ischemic injury to epithelial organ |
| 08/03/2006 | US20060172920 Oxidised lipids as reversal agents for boronic acid drugs |
| 08/03/2006 | US20060172404 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 08/03/2006 | US20060172392 Water soluble beta-glucan, glucosamine, and N-acetylglucosamine compositions and methods for making the same |
| 08/03/2006 | US20060172352 Nuclear matrix proteins |
| 08/03/2006 | US20060172348 incubating a cell or tissue sample with a purified antibody or an antigen binding fragment that binds specifically to a portion of human NAIP protein, detecting binding of antibody to such cell or tissue sample |
| 08/03/2006 | US20060172291 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 08/03/2006 | US20060172023 Use of pinolenic acid |
| 08/03/2006 | US20060172019 Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders |
| 08/03/2006 | US20060172017 Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces |
| 08/03/2006 | US20060172014 Treatment of lung cancer with active vitamin D compounds in combination with other treatments |
| 08/03/2006 | US20060172012 Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks |
| 08/03/2006 | US20060172010 Process for preparing particles containing an antiviral |
| 08/03/2006 | US20060172008 formed from plasma proteins comprising fibrinogen, thrombin and Factor XIII, the matrix having less than 10% residual moisture and being devoid of external anti-fibrinolytic agents; sponges; useful as cell-bearing implants |
| 08/03/2006 | US20060172007 Compositions and methods for reducing vaginal pH |
| 08/03/2006 | US20060172006 Sustained-release tramadol formulations with 24-hour clinical efficacy |
| 08/03/2006 | US20060172005 Tablet and process for producing the same |
| 08/03/2006 | US20060172002 Patch containing nonsteroidal antinflammatory and analgesic agent |
| 08/03/2006 | US20060171996 Antibacterial pectocellulose |
| 08/03/2006 | US20060171995 saponified plant extracts; incubtion; bioavailability |
| 08/03/2006 | US20060171993 Method of improving antioxidant status of an infant |
| 08/03/2006 | US20060171986 Antibiotic coating of implants |
| 08/03/2006 | US20060171984 Device having hydration inhibitor |
| 08/03/2006 | US20060171983 Use of Vitamin D receptor activators or Vitamin D analogs to treat cardiovascular disease |
| 08/03/2006 | US20060171978 Disinfecting and antimicrobial compositions |
| 08/03/2006 | US20060171974 Compounds, formulations, and methods for treating or preventing rosacea |
| 08/03/2006 | US20060171970 comprises diuretics and beta blockers; comprises buffer and osmotic adjusting agent; blister packs; for oral administration |
| 08/03/2006 | US20060171969 Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| 08/03/2006 | US20060171967 Means and methods for diagnosing a treponema infection |
| 08/03/2006 | US20060171956 Sphingoid polyalkylamine conjugates for hepatitis B virus vaccination |
| 08/03/2006 | US20060171954 Antigen specific activated T-lymphocytes, detection and use |
| 08/03/2006 | US20060171946 Compositions and methods for the treatment and prevention of hyperproliferative diseases |
| 08/03/2006 | US20060171945 Ip receptor antagonists for the treatment of pathological uterine conditions |
| 08/03/2006 | US20060171916 water insoluble polyallylamine copolymer (hydrochloride) crosslinked with epichlorohydrin crosslinking agent; decreasing serum level of phosphate by binding phosphate in gastrointestinal tract, without increasing absorption of any clinically undesirable material, as calcium or aluminum; hyperphosphatemia |
| 08/03/2006 | US20060171915 Blood coagulation promoter and blood collection tube |
| 08/03/2006 | US20060171911 Diiodomethyl-p-tolylsulfone as a particulate dispersion in a liquid solvent in combination with an anti-dandruff active |
| 08/03/2006 | US20060171899 Water-stabilized aerosol formulation system and method of making |
| 08/03/2006 | US20060171898 Corticosteroid-containing pharmaceutical composition |
| 08/03/2006 | US20060171896 Buccal, polar and non-polar spray containing alprazolam |
| 08/03/2006 | US20060171893 Antineoplastic agents targeted via glut transporters |
| 08/03/2006 | US20060171889 Irrigating fluid |
| 08/03/2006 | US20060171881 Compounds with high monoamine transporter affinity |
| 08/03/2006 | US20060168942 Combination of selected opioids with other active substances for use in the therapy of urinary incontinence |
| 08/03/2006 | DE60117606T2 Orale zusammensetzungen zur behandlung von kopfhauterkrankungen Oral compositions for treatment of scalp disorders |